Thryv Therapeutics Inc. is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to treat Long QT Syndrome, heart failure, and atrial fibrillation with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase. For more information, please visit www.thryvtrx.com.
Company Details
- Employees
- 27
- Founded
- -
- Address
- 999, Boulevard De Maisonneuve Ouest, Suite 1250,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- lqttrx.com
- HQ
- Montréal, Québec
Thryv Therapeutics Inc. Questions
Thryv Therapeutics Inc.'s website is lqttrx.com
Thryv Therapeutics Inc.'s LinkedIn profile is https://ca.linkedin.com/company/thryv-therapeutics-inc
Thryv Therapeutics Inc. has
27 employees.
View email and phone details for 27
employees at Thryv Therapeutics Inc..
Thryv Therapeutics Inc.'s industry is
Biotechnology Research
Thryv Therapeutics Inc.'s top competitors are
Milestone Pharmaceuticals, Inc.,
Paraza Pharma Inc.,
Specific Biologics,
Citius Pharmaceuticals, Inc.,
Find Therapeutics,
Admare Bioinnovations,
Radiant Biotherapeutics,
Jenthera Therapeutics Inc.,
Feldan Therapeutics ǀ Feldan Thérapeutiques,
Amplitude Ventures.
Thryv Therapeutics Inc.'s categories are Biotechnology Research
Thryv Therapeutics Inc.'s founding year is 2019
